Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Discover how cholesterol-lowering drug targets may reduce dementia risk through genetic insights. Keep reading.

Scientists have developed a breakthrough therapy that could revolutionise the treatment of high cholesterol, which currently ...

Scientists think those cholesterol-lowering statins might be doing something else we didn't know about: protecting our brains ...

A new DNA-based therapy could cut cholesterol nearly in half—without relying on statins or causing side effects.

Merck , known as MSD outside of the United States and Canada, today announced plans to present new research from the company's cardio-pulmonary portfolio and pipeline at the American Heart Association ...

Cardiologists often struggle to assess heart attack risk. New startups using AI could help.

An updated guideline on the management of dyslipidemias has been published by the European Society of Cardiology and European Atherosclerosis Society.

Doctors often prescribe cholesterol-lowering drugs to help people stay healthy as they get older. These medicines are mainly ...

People with genetic variants that naturally help them have lower cholesterol also have a lower risk of dementia. For those ...

McMaster researchers found that deep abdominal and liver fat can quietly damage arteries, even in people who appear fit.